Published in Physiol Genomics on April 12, 2011
Sex and gender differences in health. Science & Society Series on Sex and Science. EMBO Rep (2012) 1.15
Strategies and methods to study sex differences in cardiovascular structure and function: a guide for basic scientists. Biol Sex Differ (2011) 0.84
Estrogenic compounds are not always cardioprotective and can be lethal in males with genetic heart disease. Endocrinology (2012) 0.83
Regulation of physiological and metabolic function of muscle by female sex steroids. Med Sci Sports Exerc (2012) 0.79
Dose-dependent effects of a genistein-enriched diet in the heart of ovariectomized mice. Genes Nutr (2012) 0.78
Diet and sex modify exercise and cardiac adaptation in the mouse. Am J Physiol Heart Circ Physiol (2014) 0.78
Temporal and morphological impact of pressure overload in transgenic FHC mice. Front Physiol (2013) 0.77
Downregulation of GSTK1 Is a Common Mechanism Underlying Hypertrophic Cardiomyopathy. Front Pharmacol (2016) 0.77
Dietary fatty acids alter left ventricular myocardial gene expression in Wistar rats. Nutr Res (2014) 0.75
Sex-specific cardiovascular responses to control or high fat diet feeding in C57bl/6 mice chronically exposed to bisphenol A. Toxicol Rep (2015) 0.75
Identifying biological themes within lists of genes with EASE. Genome Biol (2003) 31.72
Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem (1987) 10.61
Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation (2000) 4.96
Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem (2002) 3.22
Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet (1997) 2.95
Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ Res (2001) 2.43
Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation (2006) 2.07
IGF-I mediated survival pathways in normal and malignant cells. Biochim Biophys Acta (2006) 1.88
Mitochondria in heart failure. Cardiovasc Res (2010) 1.75
Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. Mol Med (1996) 1.54
Soy isoflavones--benefits and risks from nature's selective estrogen receptor modulators (SERMs). J Am Coll Nutr (2001) 1.43
Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element. J Agric Food Chem (2003) 1.39
Soy diet worsens heart disease in mice. J Clin Invest (2006) 1.29
Nutritional genomics: the next frontier in the postgenomic era. Physiol Genomics (2004) 1.24
Phytoestrogens: end of a tale? Ann Med (2005) 1.15
The phytoestrogen genistein induces thymic and immune changes: a human health concern? Proc Natl Acad Sci U S A (2002) 1.14
Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene. Am J Physiol Heart Circ Physiol (2001) 1.10
Nutrigenetics/Nutrigenomics. Annu Rev Public Health (2010) 0.96
The mediating role of caspase-3 protease in the intracellular mechanism of genistein-induced apoptosis in human prostatic carcinoma cell lines, DU145 and LNCaP. Biol Cell (2000) 0.93
Genistein induces apoptosis of RPE-J cells by opening mitochondrial PTP. Biochem Biophys Res Commun (2000) 0.90
Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males. Am J Physiol Heart Circ Physiol (2006) 0.89
Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol (2002) 0.88
(Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture. Toxicol Appl Pharmacol (2007) 0.88
Effects of environmental estrogenic chemicals on AP1 mediated transcription with estrogen receptors alpha and beta. J Steroid Biochem Mol Biol (2004) 0.87
Expression of the estrogen-inducible EGFP gene in aromatase-null mice reveals differential tissue responses to estrogenic compounds. Mol Cell Endocrinol (2005) 0.77
Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation (2006) 4.69
Systematic identification of C. elegans miRISC proteins, miRNAs, and mRNA targets by their interactions with GW182 proteins AIN-1 and AIN-2. Mol Cell (2007) 4.22
Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res (2004) 2.45
A PGC-1α isoform induced by resistance training regulates skeletal muscle hypertrophy. Cell (2012) 2.35
The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity. Nature (2012) 2.33
Chromatin modifications as determinants of muscle stem cell quiescence and chronological aging. Cell Rep (2013) 2.19
Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun (2009) 2.19
Genetic variability in forced and voluntary endurance exercise performance in seven inbred mouse strains. J Appl Physiol (1985) (2002) 2.15
Notch signaling is necessary to maintain quiescence in adult muscle stem cells. Stem Cells (2012) 2.10
Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy. Circ Res (2006) 2.09
Endothelin-1 vasoconstrictor tone increases with age in healthy men but can be reduced by regular aerobic exercise. Hypertension (2007) 2.03
Aging, exercise, and endothelial progenitor cell clonogenic and migratory capacity in men. J Appl Physiol (1985) (2006) 1.92
Gene mutations and genomic rearrangements in the mouse as a result of transposon mobilization from chromosomal concatemers. PLoS Genet (2006) 1.84
Short-term triglyceride lowering with fenofibrate improves vasodilator function in subjects with hypertriglyceridemia. Arterioscler Thromb Vasc Biol (2003) 1.76
Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy. Eur Heart J (2012) 1.76
Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med (2002) 1.76
Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. Eur J Neurosci (2005) 1.73
Gender differences in circulating endothelial progenitor cell colony-forming capacity and migratory activity in middle-aged adults. Am J Cardiol (2006) 1.68
Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats. Brain Behav Immun (2006) 1.67
Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10. Mol Pain (2005) 1.66
Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain (2006) 1.66
Cooperative activation in cardiac muscle: impact of sarcomere length. Am J Physiol Heart Circ Physiol (2002) 1.61
Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity (Silver Spring) (2006) 1.59
The cell biology of disease: cellular mechanisms of cardiomyopathy. J Cell Biol (2011) 1.54
Hibernating squirrel muscle activates the endurance exercise pathway despite prolonged immobilization. Exp Neurol (2013) 1.52
Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells. Biomaterials (2005) 1.51
Competencies: a cure for pre-med curriculum. Science (2011) 1.47
Elevated endothelin-1 vasoconstrictor tone in prehypertensive adults. Can J Cardiol (2012) 1.46
Alternative polyadenylation mediates microRNA regulation of muscle stem cell function. Cell Stem Cell (2012) 1.44
Designing scaffolds for valvular interstitial cells: cell adhesion and function on naturally derived materials. J Biomed Mater Res A (2004) 1.43
Uncoupling of expression of an intronic microRNA and its myosin host gene by exon skipping. Mol Cell Biol (2010) 1.43
Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human β-cardiac myosin motor function. Proc Natl Acad Sci U S A (2013) 1.42
Redirecting valvular myofibroblasts into dormant fibroblasts through light-mediated reduction in substrate modulus. PLoS One (2012) 1.41
Fatty acids identified in the Burmese python promote beneficial cardiac growth. Science (2011) 1.30
Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner. Cancer Res (2010) 1.30
Soy diet worsens heart disease in mice. J Clin Invest (2006) 1.29
A method of mapping protein sumoylation sites by mass spectrometry using a modified small ubiquitin-like modifier 1 (SUMO-1) and a computational program. Mol Cell Proteomics (2005) 1.26
Evidence for agonist-specific endothelial vasodilator dysfunction with ageing in healthy humans. J Physiol (2002) 1.24
Loaded wheel running and muscle adaptation in the mouse. Am J Physiol Heart Circ Physiol (2005) 1.23
Hydrogels preserve native phenotypes of valvular fibroblasts through an elasticity-regulated PI3K/AKT pathway. Proc Natl Acad Sci U S A (2013) 1.20
Bioinformatics assessment of beta-myosin mutations reveals myosin's high sensitivity to mutations. Trends Cardiovasc Med (2008) 1.20
Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension. J Mol Cell Cardiol (2011) 1.19
Sex modifies exercise and cardiac adaptation in mice. Am J Physiol Heart Circ Physiol (2004) 1.18
Functional diversity among a family of human skeletal muscle myosin motors. Proc Natl Acad Sci U S A (2009) 1.18
Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain. Neuron Glia Biol (2006) 1.18
Endothelial t-PA release is impaired in overweight and obese adults but can be improved with regular aerobic exercise. Am J Physiol Endocrinol Metab (2005) 1.18
Statins block calcific nodule formation of valvular interstitial cells by inhibiting alpha-smooth muscle actin expression. Arterioscler Thromb Vasc Biol (2009) 1.16
Sex-based cardiac physiology. Annu Rev Physiol (2009) 1.13
Pregnancy as a cardiac stress model. Cardiovasc Res (2014) 1.11
MyoD, Myf5, and the calcineurin pathway activate the developmental myosin heavy chain genes. Dev Biol (2006) 1.09
The effects of biological sex and diet on the development of heart failure. Circulation (2007) 1.07
Intracellular calcium and myosin isoform transitions. Calcineurin and calcium-calmodulin kinase pathways regulate preferential activation of the IIa myosin heavy chain promoter. J Biol Chem (2002) 1.07
SUMO-1 modification of MEF2A regulates its transcriptional activity. J Cell Mol Med (2006) 1.06
Identification of functional differences between recombinant human α and β cardiac myosin motors. Cell Mol Life Sci (2012) 1.06
Restoration of CREB function is linked to completion and stabilization of adaptive cardiac hypertrophy in response to exercise. Am J Physiol Heart Circ Physiol (2007) 1.06
Integrin-linked kinase production prevents anoikis in human mesenchymal stem cells. J Biomed Mater Res A (2007) 1.05
Skeletal myosin heavy chain function in cultured lung myofibroblasts. J Cell Biol (2003) 1.05
Tropomyosin 3 expression leads to hypercontractility and attenuates myofilament length-dependent Ca(2+) activation. Am J Physiol Heart Circ Physiol (2002) 1.03
Erratum to: Identification of functional differences between recombinant human α and β cardiac myosin motors. Cell Mol Life Sci (2012) 1.01
Myocyte enhancer factor-2 and serum response factor binding elements regulate fast Myosin heavy chain transcription in vivo. J Biol Chem (2005) 1.01
Enhanced endothelin-1 system activity with overweight and obesity. Am J Physiol Heart Circ Physiol (2011) 1.00
Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T. Circulation (2004) 0.99
Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy. Circ Res (2003) 0.98
Mutations in the beta-myosin rod cause myosin storage myopathy via multiple mechanisms. Proc Natl Acad Sci U S A (2009) 0.98
Micro-RNA-195 and -451 regulate the LKB1/AMPK signaling axis by targeting MO25. PLoS One (2012) 0.98
Akt and MAPK signaling mediate pregnancy-induced cardiac adaptation. J Appl Physiol (1985) (2012) 0.97
Expression of cardiac troponin T with COOH-terminal truncation accelerates cross-bridge interaction kinetics in mouse myocardium. Am J Physiol Heart Circ Physiol (2004) 0.97
Impaired endothelium-dependent vasodilation in overweight and obese adult humans is not limited to muscarinic receptor agonists. Am J Physiol Heart Circ Physiol (2008) 0.97
Whole transcriptome analysis of the fasting and fed Burmese python heart: insights into extreme physiological cardiac adaptation. Physiol Genomics (2010) 0.95
Mutations at the same amino acid in myosin that cause either skeletal or cardiac myopathy have distinct molecular phenotypes. J Mol Cell Cardiol (2009) 0.94
Gender differences in endothelial tissue-type plasminogen activator release in middle-aged adults. J Am Coll Cardiol (2005) 0.94
Aging and endothelial progenitor cell telomere length in healthy men. Clin Chem Lab Med (2009) 0.94
Activation of serum/glucocorticoid-induced kinase 1 (SGK1) is important to maintain skeletal muscle homeostasis and prevent atrophy. EMBO Mol Med (2012) 0.94
IIb or not IIb? Regulation of myosin heavy chain gene expression in mice and men. Skelet Muscle (2011) 0.93
Loss of desmin leads to impaired voluntary wheel running and treadmill exercise performance. J Appl Physiol (1985) (2003) 0.93
Crystal structure of NFAT bound to the HIV-1 LTR tandem kappaB enhancer element. Structure (2008) 0.93
Yin Yang 1 represses alpha-myosin heavy chain gene expression in pathologic cardiac hypertrophy. Biochem Biophys Res Commun (2005) 0.92
Impaired endothelium-dependent vasodilation in normotensive and normoglycemic obese adult humans. J Cardiovasc Pharmacol (2006) 0.92
Endothelial progenitor cell function, apoptosis, and telomere length in overweight/obese humans. Obesity (Silver Spring) (2010) 0.91
All's well that ends well: alternative polyadenylation and its implications for stem cell biology. Curr Opin Cell Biol (2013) 0.91
A randomized library approach to identifying functional lox site domains for the Cre recombinase. Nucleic Acids Res (2007) 0.90
The role of Akt/GSK-3beta signaling in familial hypertrophic cardiomyopathy. J Mol Cell Cardiol (2009) 0.90
Increased thermoregulation in cold-exposed transgenic mice overexpressing lipoprotein lipase in skeletal muscle: an avian phenotype? J Lipid Res (2008) 0.90
Human aging and CD31+ T-cell number, migration, apoptotic susceptibility, and telomere length. J Appl Physiol (1985) (2010) 0.90
Short sleep duration is associated with enhanced endothelin-1 vasoconstrictor tone. Can J Physiol Pharmacol (2010) 0.90
Fighting fat with muscle: bulking up to slim down. Cell Metab (2008) 0.90
Effects of pathogenic proline mutations on myosin assembly. J Mol Biol (2011) 0.90
Metabolic crosstalk between the heart and liver impacts familial hypertrophic cardiomyopathy. EMBO Mol Med (2014) 0.90
Myh7b/miR-499 gene expression is transcriptionally regulated by MRFs and Eos. Nucleic Acids Res (2012) 0.89
Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males. Am J Physiol Heart Circ Physiol (2006) 0.89
Aging is associated with a proapoptotic endothelial progenitor cell phenotype. J Vasc Res (2011) 0.89
Myosin heavy chain is not selectively decreased in murine cancer cachexia. Int J Cancer (2011) 0.89
Calcineurin activity is required for cardiac remodelling in pregnancy. Cardiovasc Res (2013) 0.88
Intrathecal injection of naked plasmid DNA provides long-term expression of secreted proteins. Mol Ther (2008) 0.88